Effect of epinephrine on muscle glycogenolysis and insulin-stimulated muscle glycogen synthesis in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 274, Issue 1 37-1, 1998, Pages

  Laurent, Didier ^a   Petersen, Kitt Falk ^a   Russell, Raymond R ^a   Cline, Gary W ^a   Shulman, Gerald I ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Energy expenditure; Glucose oxidation; Lipid oxidation; Nuclear magnetic resonance spectroscopy

Indexed keywords

ADULT; ARTICLE; ENERGY EXPENDITURE; FEMALE; GLUCOSE OXIDATION; GLYCOGEN MUSCLE LEVEL; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; HUMAN; INSULIN METABOLISM; LIPID OXIDATION; MALE; MUSCLE METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031910907     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1998.274.1.e130     Document Type: Article

References (45)

1. Altszuler, N., R. Steele, I. Rathgeb, and R. C. De Bodo. Glucose metabolism and plasma insulin level during epinephrine infusion in the dog. Am. J. Physiol. 212: 677-682, 1967.
2. Baron, A. D., P. Wallace, and J. M. Olefsky. In vivo regulation of non-insulin-mediated and insulin-mediated glucose uptake by epinephrine. J. Clin. Endocrinol. Metab. 64: 889-895, 1987.
3. 31P NMR measurement of glucose-6-phosphate in the rat muscle after exercise. Magn. Reson. Med. 30: 347-350, 1993.
4. Bloch, G., J. R. Chase, D. B. Meyer, M. J. Avison, G. I. Shulman, and R. G. Shulman. In vivo regulation of rat muscle glycogen resynthesis after intense exercise. Am. J. Physiol. 266 (Endocrinol. Metab. 29): E85-E91, 1994.
5. Capaldo, B., R. Napoli, L. Di Marino, and L. Saccà. Epinephrine directly antagonizes insulin-mediated activation of glucose uptake and inhibition of free fatty acid release in forearm tissues. Metabolism 41: 1146-1149, 1992.
6. Chasiotis, D. The regulation of glycogen phosphorylase and glycogen breakdown in human skeletal muscle. Acta Physiol. Scand. Suppl. 518: 1-68, 1983.
7. Chasiotis, D., K. Sahlin, and E. Hultman. Regulation of glycogenolysis in human muscle at rest and during exercise. J. Appl. Physiol. 53: 708-715, 1982.
8. Chasiotis, D., K. Sahlin, and E. Hultman. Regulation of glycogenolysis in human muscle in response to epinephrine infusion. J. Appl. Physiol. 54: 45-50, 1983.
9. Chiasson, J. L., H. Shikama, D. T. W. Chu, and J. H. Exton. Inhibitory effect of epinephrine on insulin-mediated glucose uptake by rat skeletal muscle. J. Clin. Invest. 68: 706-713, 1981.
10. Christensen, N. J. Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration. Diabetes 23: 1-8, 1974.
11. Cori, F. C., and G. T. Cori. The mechanism of epinephrine action. J. Biol. Chem. 79: 309-355, 1928.
12. 11a. Cryer, P. E. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N. Engl. J. Med. 303: 436-444, 1980.
13. DeFronzo, R. A., J. E. Tobin, and R. Andres. Glucose-clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E214-E223, 1979.
14. Deibert, D. C., and R. A. DeFronzo. Epinephrine-induced insulin resistance in man. J. Clin. Invest. 65: 717-721, 1980.
15. Dietz, M. R., J. L. Chiasson, T. R. Soderling, and J. H. Exton. Epinephrine regulation of skeletal muscle glycogen metabolism. Studies using the perfused rat hindlimb preparation. J. Biol. Chem. 255: 2301-2307, 1980.
16. Eigler, N., L. Saccà, and R. S. Sherwin. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog. J. Clin. Invest. 63: 114-123, 1979.
17. Fisher, E. H., L. M. G. Heilmayer, Jr., and R. H. Haschke. Phosphorylase and the control of glycogen degradation. Curr. Top. Cell. Regul. 4: 211-251, 1971.
18. Fredholm, B. B., L. O. Farnebo, and B. Hamberger. Plasma catecholamines, cyclic AMP and metabolic substrates in hemorrhagic shock of the rat. The effect of adrenal demedullation and 6-OH-dopamine treatment. Acta Physiol. Scand. 105: 481-495, 1979.
19. Fryburg, D. A., R. A. Gelfand, L. A. Jahn, D. Oliveras, R. S. Sherwin, L. Saccà, and E. J. Barret. Effects of epinephrine on human muscle glucose and protein metabolism. Am. J. Physiol. 268 (Endocrinol. Metab. 31): E55-E59, 1995.
20. Galbo, H., J. J. Holst, and N. J. Christensen. Glucagon and plasma catecholamine responses to graded and prolonged exercise in man. J. Appl. Physiol. 38: 70-76, 1975.
21. Garber, A. J., P. E. Cryer, J. V. Santiago, M. W. Haymond, A. S. Pagliara, and D. M. Kipnis. The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J. Clin. Invest. 58: 7-15, 1976.
22. Górski, J. Exercise-induced changes of reactivity of different types of muscle on glycogenolytic effect of adrenaline. Pflügers Arch. 373: 1-7, 1978.
23. 13C NMR visibility of rabbit muscle glycogen in vivo. Magn. Reson. Med. 20: 327-332, 1991.
24. Halter, J. B., A. E. Pflug, and D. Porte. Mechanism of plasma catecholamine increases during surgical stress in man. J. Endocrinol. Metab. 45: 936-944, 1977.
25. Harris, R. C., E. Hultman, and L. O. Nordesjo. Glycogen, glycolytic intermediates and high energy phosphates determined in biopsy samples of musculus quadriceps femoris of man at rest. Methods and variance of values. Scand. J. Clin. Lab. Invest. 33: 109-120, 1974.
26. 13C NMR study of glycogen repletion in human liver and muscle. Proc. Natl. Acad. Sci. USA 86: 1439-1442, 1989.
27. Manheim, P., H. Lecerof, and B. Hökfelt. Plasma catecholamine levels in the coronary sinus, the left renal vein and peripheral vessels in healthy males at rest and during exercise. Acta Physiol. Scand. 104: 364-369, 1978.
28. Nolte, L. A., E. A. Gulve, and J. O. Holloszy. Epinephrine-induced in vivo muscle glycogen depletion enhances insulin sensitivity of glucose transport. J. Appl. Physiol. 76: 2054-2058, 1994.
29. Porte, D. A receptor mechanism for the inhibition of insulin release by epinephrine in man. J. Clin. Invest. 46: 86-94, 1967.
30. Price, T. B., D. L. Rothman, R. Taylor, M. J. Avison, G. I. Shulman, and R. G. Shulman. Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases. J. Appl. Physiol. 76: 104-111, 1994.
31. Rattigan, S., G. J. Appleby, S. J. Edwards, W. J. McKinstry, E. Q. Colquhoun, and M. G. Clark. α-Adrenergic receptors in rat skeletal muscle. Biochem. Biophys. Res. Commun. 136: 1071-1077, 1986.
32. Raz, I., A. Katz, and M. K. Spencer. Epinephrine inhibits insulin-mediated glycogenesis but enhances glycolysis in human skeletal muscle. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E430-E435, 1991.
33. Ren, J. M., and E. Hultman. Regulation of glycogenolysis in human skeletal muscle. J. Appl. Physiol. 67: 2243-2248, 1989.
34. Roden, M., G. Perseghin, K. F. Petersen, J. H. Hwang, G. W. Cline, K. Gerow, D. L. Rothman, and G. I. Shulman. The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans. J. Clin. Invest. 97: 642-648, 1996.
35. Roden, M., T. B. Price, G. Perseghin, K. F. Petersen, D. L. Rothman, G. W. Cline, and G. I. Shulman. Mechanism of free fatty acid-induced insulin resistance in humans. J. Clin. Invest. 97: 2859-2865, 1996.
36. Rothman, D. L., I. Magnusson, G. W. Cline, D. Gerard, C. R. Kahn, R. G. Shulman, and G. I. Shulman. Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 92: 983-987, 1995.
37. 31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. J. Clin. Invest. 89: 1069-1075, 1992.
38. Saccà, L., N. Eigler, P. E. Cryer, and R. S. Sherwin. Insulin antagonistic effects of epinephrine and glucagon in the dog. Am. J. Physiol. 237 (Endocrinol. Metab. Gastrointest. Physiol. 6): E487-E492, 1979.
39. 13C nuclear magnetic resonance spectroscopy. N. Engl. J. Med. 322: 223-228, 1990.
40. Soderling, R. T., and C. R. Park. Recent advances in glycogen metabolism. Adv. Cyclic Nucleotide Res. 4: 283-333, 1974.
41. Stevenson, R. W., K. E. Steiner, C. C. Connoly, H. Fuchs, K. G. M. M. Alberti, P. E. Williams, and A. D. Cherrington. Dose-related effects of epinephrine on glucose production in conscious dogs. Am. J. Physiol. 260 (Endocrinol. Metab. 23): E363-E370, 1991.
42. 13C NMR measurement of human skeletal muscle glycogen by direct biochemical assay of needle biopsy samples. Magn. Reson. Med. 27: 13-20, 1992.
43. Watts, D. T. Adrenergic mechanisms in hypovolemic shock. In: Shock and Hypotension, edited by L. C. Mills and J. K. Moyer. New York: Grune and Stratton, 1965, p. 385-391.
44. Wolfe, R. R. Tracers in metabolic research: radioisotope and stable isotope mass spectrometry methods. In: Laboratory and Research Methods in Biology and Medicine. New York: Liss, 1984, vol. 9, p. 207-232.
45. Yki-Järvinen, H., C. Bogardus, and B. V. Howard. Hyperglycemia stimulates carbohydrate oxidation in humans. Am. J. Physiol. 253 (Endocrinol. Metab. 16): E376-E382, 1987.